Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aleva Neurotherapeutics

Request full access

Pioneered directional deep brain stimulation DBS in Neuromodulation treatment of Parkinson's disease and essential tremor

Lausanne, SwitzerlandFounded 2013Biotech & Life Sciences

About Aleva Neurotherapeutics

Aleva Neurotherapeutics is a Swiss-based startup that specializes in the development and commercialization of Deep Brain Stimulation (DBS) technologies. Originating as a spin-off from the Swiss Federal Institute of Technology, the company's primary goal is to enhance the existing DBS treatment for patients suffering from neurological disorders. DBS is a medical procedure used to treat a variety of debilitating neurological symptoms—most commonly the debilitating symptoms of Parkinson’s disease, such as tremor, rigidity, stiffness, slowed movement, and walking problems.

Aleva has pioneered the directional mode of DBS, a more sophisticated technology that has set the industry standard for directional leads. This technology allows for more precise stimulation of specific areas of the brain, potentially reducing side effects and improving patient outcomes. The company holds 13 patent families and 90 granted patents in this area, demonstrating its expertise and commitment to innovation.

Aleva's business model revolves around partnering with leading neurological clinics in Europe, with plans to expand into worldwide markets in the near future. The company's revenue is generated through the sale of its directSTIM™ system, a DBS solution designed to eliminate surgical failures and non-responder patients. This system is fully manufactured and assembled in Switzerland, adhering to the highest quality standards.

In summary, Aleva Neurotherapeutics is a forward-thinking company dedicated to improving the lives of patients with neurological disorders through the development and commercialization of innovative DBS technologies.

Source: Dealroom company data

Aleva Neurotherapeutics in the Lausanne ecosystem

Live from Dealroom

The Aleva Neurotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • BioMedVC
  • Banexi Ventures Partners
  • Kreaxi

Series B and later5 investors entered at this stage

  • Fondation FIT
  • Integer Holdings
  • Kinled Holding
  • BB Biotech Ventures
  • Forrestal Capital
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇭🇰 Hong Kong50%
🇨🇭 Switzerland50%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aleva Neurotherapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aleva Neurotherapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.